MDB Capital Collaborates with Mayo Clinic to Advance Anti-Senescence Platform

ADDISON, Texas, July 08, 2024 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) ("MDB"), a public venture platform focused on launching category-leading deep technology companies, today announced a collaboration through a patent and know-how agreement with Mayo Clinic to develop a small molecule anti-senescence platform. This collaboration aims to advance research in longevity and age-related disease prevention. Studies conducted at Mayo Clinic have shown the potential of the licensed molecule t ...